Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study (Q77218302)
Jump to navigation
Jump to search
scientific article published on 01 September 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study |
scientific article published on 01 September 1998 |
Statements
Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study (English)
Coiffier B
Ketterer N
Engert A
Tilly H
Ma D
Johnson P
Lister A
Feuring-Buske M
Radford JA
Capdeville R
Diehl V
1 September 1998